AIM ImmunoTech Announces Commencement of Phase 2 Study of Ampligen® for[...]
08/02/2022 | Press release | Distributed by Public on 08/03/2022 01:43
Please select the service you want to use:
Smartlinks | KCB Group Ltd. | Company News | Mergers and Acquisitions | Financial Services | Banking | Professional and Business Services | Legal Services | Public Companies | Banks | Nairobi Securities Exchange (NSE Kenya) | Dar es Salaam Stock Exchange | Rwanda Stock Exchange | Uganda Securities Exchange
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact